BioStock: Chordate Medical enters agreement in Switzerland

Chordate Medical adds Switzerland as a new focus market for the Ozilia migraine treatment entering into a new partnership agreement with Neurolite, a well-established distributor in neurology in Switzerland.
– Neurolite has a complete grasp of the entire neurology market, with well-established relationships with a large portion of all relevant customers, says Chordate’s CEO Anders Weilandt.

Read the full article at biostock.se:

https://www.biostock.se/en/2024/06/chordate-medical-enters-agreement-in-switzerland/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se